DHPC – Besponsa (Inotuzumab Ozogamicin)

Haarrisse im Boden einer Durchstechflasche


Out-of-Stock – Noxafil, Konzentrat zur Herstellung einer Infusionslösung

Befristete Bewilligung zum Vertrieb in dänischer/norwegischer/isländischer Aufmachung


Out-of-Stock – Addaven, Infusionskonzentrat

Befristete Bewilligung zum Vertrieb in englischer Aufmachung


Swissmedic Journal

Latest edition
Swissmedic Journal Juli 2022


Update on the replacement of the medical professions register MedReg

by the new Health Professions Platform (HealthReg)


Batch recall – NeoCitran Schnupfen/Erkältung, Filmtabletten

Rückruf der Charge 2201145 bis auf Stufe Detailhandel


Pfizer applies for an authorisation extension for a coronavirus vaccine against Omicron

Comirnaty: Swissmedic starts rolling review of a bivalent COVID-19 vaccine


Changes to Guidance document Authorisation procedures for COVID-19 medicinal products during a pandemic HMV4

Filing of Submission Plans to evaluate the efficacy of existing COVID-19 medicinal products against new SARS-Cov-2 variants

In focus


COVID-19 Pandemic

Information on the new coronavirus (SARS-CoV-2)

Vaccines against COVID-19

20 years Swissmedic

Anniversary message from the Director

Happy Birthday Swissmedic

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to anfragen@swissmedic.ch or use our contact form. Thank you.

Direct links

Stay up to date

Reporting undesirable effects and incidents


Medical devices

Swiss Public Assessment Report (SwissPAR)


Public Summary SwissPAR


Illegal medicinal products from the Internet

Find out in this video why you should be careful when buying medicinal products online, and what happens if customs officials discover that a consignment addressed to you contains illegally imported medicinal products.



New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.


Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019


What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.

Swissmedic, Swiss Agency for Therapeutic Products


Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...